Select Committee on European Union Written Evidence


Memorandum by GE Life

1.  COMPANY INFORMATION

  1.1  GE Life is a fully owned subsidiary of GE Insurance Holdings and belongs to the General Electric Company (GE). GE is a diversified technology, manufacturing and services company founded on over a century of achievement and innovation employing over 330,000 people worldwide. GE's EMEA operations represent a major part of its overall business activities and growth strategy. In 2003, these businesses generated Euro 32 billion in sales and employed 75,000 people. GE's commitment to Europe, through increasing investment and employment, including the opening of a branch of its Global Research Centre in Munich, reflects its global strategy. GE is also a leading player in the financial services industry with businesses active in consumer and commercial finance activities as well as in the insurance sector, including reinsurance and mortgage insurance.

  1.2  In the UK GE Life offers a broad range of products for both at- and post-retirement including a comprehensive set of retirement Drawdown solutions, self-invested personal pensions and transfer plans. GE Life further offers supplementary retirement options allowing its customers to generate additional income for retirement, including specialist annuities, equity release income plans and structured investment products.

  1.3 One of GE Life's principal focuses is the conversion of accumulated wealth into income in retirement. We have a leading position in the specialist annuity market and were one of the first firms to introduce Drawdown in July 1995. As such we have a long and successful track record in this segment of the market—the segment of the pensions market that would be most directly affected by the proposed Directive.

2.  OVERVIEW

  2.1  GE Life welcomes the opportunity offered by the EU Sub-Committee on Social Policy and Consumer Affairs of the House of Lords to comment on the proposal of the European Commission for a Council Directive implementing the principle of equal treatment between women and men in the access to and supply of goods and services (COM 2003-657).

  2.2  The proposed Directive lays down a framework for combating gender discrimination in the supply of goods and services. The European Commission, in setting the context for the Directive, argues that: "Equal treatment between men and women and non-discrimination on grounds of sex are fundamental principles of Community law".

  2.3  GE Life supports this general principle. As a company we already maintain a strong commitment to promoting the fair treatment of individuals. This commitment can be demonstrated clearly through both our role as an equal opportunities employer, and as a leading provider of insurance and financial services.

  2.4  GE Life believes this to be wholly consistent with our strong belief in the principle of risk-based premium pricing. GE Life currently adopts this principle with regard to a wide range of insurance-based retirement products. This is in keeping with common UK industry practice. Of particular concern to GE Life is the provision contained within Article 4 of the Directive requiring Member States to prohibit the use of gender as a factor in the calculation of premiums and benefits for the purpose of insurance and related financial services.

  2.5  GE Life wishes to emphasize that the proposal as currently drafted will have a significant negative impact on its operations and more specifically on its annuities based life insurance products. GE Life would request that the EU Sub-Committee give particular consideration to the following factors in formulating their response towards the EU Commission's proposals.

3.  THE BUSINESS CASE FOR RISK-BASED PRICING

Industry Practice

  3.1  The basic principle of all private insurance models is the need to undertake an accurate assessment of risk. Insurers typically use a whole range of rating factors to determine (in some instances on a case-by-case basis) the level of risk when insuring each individual or organisation. From this perspective, any premium calculation needs to be based on statistical, scientifically justified and objective data in order to allow the insurance to appropriately cover future liabilities.

  3.2  The Financial Services Authority (FSA) has taken a strong lead over recent years in encouraging firms to develop a greater awareness of risk across a number of fronts. This can be demonstrated by the ongoing changes to insurers' prudential rules under the EU's solvency II review, and the FSA's approach to Individual Capital Adequacy Standards (ICAS). Meanwhile, the provisions governing firms' conduct of business, such as the FSA "know-your-customer" requirements, stress the importance of understanding consumer risk. With the development of a risk-based approach in all areas of financial regulation it is now widely accepted that the need to identify and manage risk is vital in ensuring more effective and efficient markets.

  3.3  The fact that UK insurers have already developed sophisticated approaches to risk-based pricing is not only consistent with this regulatory approach, but has a long track record in generating widespread benefits to consumers. Varying premiums in accordance with risk effectively rewards the consumer for good behaviour and reduces possible moral hazard. Of course, not all factors are variable (including gender) but they form an important indicator of risk none-the-less.

The Gender Gap

  3.4  It has been widely reported throughout the popular press that women receive unfavourable treatment when compared to men as a result of risk-based gender pricing (as is generally the case with life insurance products). However, in other cases the outcome has been reversed with men generally paying higher premiums (as with motor insurance). GE Life argue that this is natural given the different risk profile of men and women, and it should not be held up as an example of gender discrimination.

  3.5  With regard to annuity products the tradition of gender-based risk pricing is well established. Mortality tables and morbidity tables are widely used in life and health insurance and help to deliver objective data. In the UK the Continuous Mortality Investigation Bureau (CMIB) plays a leading role in collating and analysing the most recent data for use by the insurance industry.

  3.6   The most recent figures revealed that the gender gap in life expectancy has reduced in recent years. In fact, this has been the established trend over recent decades. However, the degree to which gender differences persist is an important consideration for policymakers, and one which deserves further examination.

  3.7  On this crucial point it has been statistically, scientifically and objectively proven using CMIB data, as well as other independent sources, that life expectancy for women remains significantly longer than for men. For a man aged 65 the life expectancy is 81. This is three years less than the 84 years life expectancy for a woman aged 65. While this does represent a fall in the gender gap, from 4.5 years in 1990, the difference between men and women is still significant.

  3.8  Given women's longer life expectancy, an annuity providing a fixed amount of income for life is worth more to her than to a man and it is exactly on that ground that women pay higher premiums. If men and women were to pay the same premiums for an annuity based life insurance, this would constitute a discrimination against men as not only they would benefit from annuities for a shorter period of time than women who have paid the same premium, and would result in men cross-subsidizing women's pensions.

  3.9  By differentiating the premium between men and women, insurance companies take into account an objective fact and do not in any way violate the non-discrimination principle laid down in Article 13 of the EC Treaty (which is the legal basis for the proposed Directive).

  3.10  GE Life's position is that an appropriate interpretation of this provision means that discrimination may exist when:

    —  similar cases are treated differently or;

    —  different cases are treated similarly.

  In the case of life insurance, however, the situation of men and women is objectively different and therefore justifies a differentiated treatment.

4.  THE "UNFORESEEN" REGULATORY IMPACT

Proportionate Regulation

  4.1  GE Life has considered the proposals closely and firmly believes that certain elements have not been sufficiently examined by the European Commission. Furthermore, the failure to undertake an in-depth cost-benefit analysis could lead to negative outcomes, which will be unforeseen by legislators.

  4.2  Under the UK financial framework any measures emanating from the FSA must, in accordance with Part 1 of the Financial Services and Markets Act (2000), give regard to "the principle that a burden or restriction which is imposed on a person, or on the carrying on of an activity, should be proportionate to the benefits, which are expected to result from the imposition". As part of this approach the FSA is required to undertake a cost-benefit analysis justifying the need for regulatory action.

  4.3  The European Commission is not subjected to a similar requirement. The danger for unnecessary regulatory impacts is therefore an ongoing threat. In the case of the proposed Directive any additional costs will have severe impacts on the consumer through the potential for a general increase in the level of premiums or a reduction in annuities products that are made available.

  4.4  GE Life therefore calls on the UK Government as a matter of urgency to work with the Commission to undertake the studies that clearly demonstrate the cost neutrality of the proposed measures.

  4.5  Whilst GE Life welcomes the European Commission's decision to adopt a long lead-in period for implementation (with the implementation date set for 2008), the requirement for gender neutrality appears at best misguided. The fact that the Directive explicitly seeks to undermine the principle of risk-based pricing will over the long-term prove to be socially inequitable. As we have already outlined (Para 3.8) the proposals will result in low-risk consumers paying higher premiums in order to subsidise reduced premiums to high-risk individuals. Removing risk from insurance pricing is also likely to increase the level of moral hazard.

The position of UK pensions savings

  4.6  The danger of negative regulatory impacts is particularly pertinent given the size and nature of the UK pensions industry. The UK is in a small minority of EU Member States that have well developed private pensions savings. The so-called third pillar of personal pensions is still largely in its infancy in many EU countries as they are only just beginning to grapple with the long-term sustainability of their existing (largely publicly funded) pensions arrangements.  

  4.7  The impact of introducing gender-neutral annuities is therefore marginal for most European countries, as their citizens are far less likely to contribute into a personal pension. Consequently, it will be the case that they are less likely to be required to purchase annuity products in retirement. Therefore the negative impacts will be felt disproportionately in the UK. The concerns of the UK should therefore be a major consideration for EU policymakers before proposing any legislative changes, which are designed to specifically impact upon insurance-based pensions saving.

  4.8  If Member States decide that this provision should be maintained in the Directive, GE Life would call for a UK derogation from the prohibition of sex discrimination that would allow gender to be used as a differentiating factor if such use was based on objective and statistical data.

5.  CONCLUDING REMARKS

  5.1  GE Life wishes to emphasise that we fully support the goal of the proposed Directive, which consists in eliminating the discrimination between men and women. Our comments are solely directed at Article 4, and the provisions covering insurance and other related financial services.

  5.2  We wish to reiterate our gratitude for being invited to participate in this consultation process and we will be happy to answer any further questions you may have or provide you with any additional information you may deem useful.

28 April 2004



 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2004